Premier Fund Managers’s Definium Therapeutics DFTX Stock Holding History

Premier Fund Managers’s Portfolio DFTX Stock Details DFTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.35M	Buy	+61,428	New	+$2.59M	0.24%	101

Other funds holding DFTX

Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return

AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

SEB Asset Management Stockholm $27B AUM

ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return

Moody Aldrich Partners Marblehead, Massachusetts $523M AUM 75.24% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Kestra Private Wealth Services Austin, Texas $9.37B AUM 22.72% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return

Peak Financial Advisors Denver, Colorado $232M AUM 12.16% 1-Year Est. Return

Premier Fund Managers's DFTX Position: Q3 2026 in Review

Premier Fund Managers opened a new position in Definium Therapeutics (DFTX) in Q3 2026: 61,428 shares worth $2.35M. The stake represents 0.24% of the portfolio and ranks #101 among its holdings.

103 funds tracked by Wall St. Rank hold DFTX as of Q3 2026.

Premier Fund Managers held 61,428 shares of Definium Therapeutics worth $2.35M as of Q3 2026.
Definium Therapeutics was a new Premier Fund Managers position in Q3 2026.
Definium Therapeutics made up 0.24% of Premier Fund Managers's portfolio in Q3 2026, its #101 holding.
103 funds tracked by Wall St. Rank held Definium Therapeutics as of Q3 2026.

Based on Premier Fund Managers's 13F filing for Q3 2026, filed 2 Nov 2026.